Navigation Links
NightHawk Radiology exclusive radiology provider for high-risk plaque research initiative
Date:1/30/2008

tHawks resources, flexibility, and expertise place them at the forefront of CCTA and the 3D reconstruction. They are the only global provider with a viable solution that is available today.

NightHawk Radiology Services has deployed an independent imaging network solution explicitly for the HRP Initiative and it expects to begin evaluating reads in the first quarter of 2008.

We are very excited to be a part of this initiative, which involves high-profile medical institutions, leading pharmaceutical and medical technology companies, and scientists in the fields of cardiology, pathology, and imaging, said Dr. Paul Berger, Chairman and Chief Executive Officer of NightHawk Radiology Services. Participating in this initiative builds on the opportunities that lie ahead for our new service offerings such as CCTA, which we believe will continue to gain acceptance as the standard non-invasive diagnostic tool.


'/>"/>

Contact: Robert Minicucci
robert@warnerpr.com
603-488-5856
Warner Communications
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
2. NightHawk Radiology Holdings, Inc. Releases Record Third Quarter 2007 Results
3. NightHawk Radiology Holdings, Inc. to Speak at Annual Piper Jaffray Healthcare Conference on November 28, 2007
4. NightHawk Radiology: One Source, One Solution
5. NightHawk Radiology Holdings, Inc. to Speak at Annual JPMorgan Healthcare Conference on January 10, 2008
6. NightHawk Radiology Holdings, Inc. Announces Preliminary 2007 Results
7. NightHawk Radiology Holdings, Inc. Announces Date for Fourth Quarter and Full-Year 2007 Earnings Conference Call
8. AIUM CEO named among most influential in radiology
9. Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
10. Franklin & Seidelmann Enters Full-Service Teleradiology Market with Acquisition of Apex Radiology
11. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...TORONTO, Jan. 8 /PRNewswire-FirstCall/ - Med-Emerg... of Canada,s leading providers of health services,... voted in favour of the previously announced plan ... Group Inc. ("AIM") at a special meeting of MedEme... of 90% of the votes cast at the meeting were in f...
(Date:1/8/2009)...ALEXANDRIA, Va., Jan. 8 ...rganization along with several national leadership...ing the principles of hospice care and protection ... standing together in sharing this unified message...on of Hospice and Palliative Medicine, Hospice and...
(Date:1/8/2009)...California Assembly Member Tom Torlakson Introduce...ire-USNewswire/ -- Today, Lung Cancer Alliance-C...ber Tom Torlakson (D-11th District) for his contin...g funding for lung cancer research. For the third...g cancer research is being considered in the Calif...
(Date:1/8/2009)...ew says it lowered bad cholesterol more effectivel...hDay News) -- After nearly a year of review, U.S. ... the continued use of the controversial cholestero...ug Administration said there was no significant di...nts taking Vytorin and patients taking the drug Zo...
Breaking Medicine News(10 mins):Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2
...to ten, identified colours and even dabbled with F...an IQ test that her soaring brainpower was establi...e youngest female celebrated member of Mensa. The ...chief executive and a carpenter, Georgia has been ...
...nteers are participating in a six-day long rally h...drug trafficking. Adorning characteristic yellow...e streets of Imphal to send across the message on ...ugs. Over 350 cyclists and 200 volunteers are part...
...merican Journal of Gastroenterology, indicates tha...nd 304 patients has confirmed that polyethylene (...chronic constipation, even elderly patients can us... Until recently, few data were available regardin...
...bly heavier than others. Researchers at the US Na...se Control and Prevention and the Cincinnati Chil...ormones could be contributing to such a phenomenon...children with autism have very rapid head growth i...
Other Medicine News:Health News:Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius 2Health News:Autism Could Be Related to Higher Level of Growth Hormones 2
(Date:1/7/2009)...IS, Jan. 7 Eli Lilly and...eceived a complete response letter from,the U.S. ...long-acting,injection (LAI) for acute and mainten...is continuing to work with the agency on the new d...require any additional clinical trials for the con...
(Date:1/7/2009)..., Jan. 7 ImQuest Life Sciences ann...pplication to the Food and Drug Administration to ...midinedione HIV inhibitor IQP-0410. ImQuest antici...t quarter of 2009. IQP-0410 is a novel small molec...nucleoside reverse transcriptase inhibitor (NNRTI)...
(Date:1/7/2009)...gland, January 7 Circassia Ltd, a ...lergy and critical care, today,announced that fol...8 with,its ToleroMune(R) anti-allergy technology,...t for a further phase II clinical trial in cat all... recruited 120 patients with confirmed,cat allerg...
(Date:1/6/2009)... Jan. 6 In recent controlled studi...f Memphis , scientists found that the patented ing...st and only proven ingredient to increase levels o...g blood nitrate/nitrate (NOx) in human subjects. ,...es an increase in blood flow to the skeletal muscl...
Breaking Medicine Technology:FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2IBT Laboratories Expands its Menu of Tests for Immune Deficiency 3525 1IBT Laboratories Expands its Menu of Tests for Immune Deficiency 3525 2These shells dont clam up 3A Innovative technique to record human impact on coastal waters 6127 1EIN News Introduces Brain Cancer News Today 3B Website Offers Information on Risk Factors Treatment Drugs 31054 1EIN News Introduces Brain Cancer News Today 3B Website Offers Information on Risk Factors Treatment Drugs 31054 2Gene which protects against lung cancer identified 31049 1Gene which protects against lung cancer identified 31049 2
...ELS, Belgium and KOS, Greece, June 29, 2007 /PRNew... updated data for,previously treated patients on R...one shows median survival of 35 months, nearly,thr...mized,controlled Phase III trials that enrolled mo...s worldwide. These updated results,were presented ...
... Presentation of efficacy trends from ongoing phas... ESMO for presentation in,press conference , MARTI...ny,MediGene AG (Frankfurt, Prime Standard: MDG) an...al trial of MediGene,s cancer killing,virus will b...pean,Society for Medical Oncology. Out of more tha...
Other Medicine Technology:The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2European Society for Medical Oncology (ESMO) Presents Data from the,Clinical Trial of MediGene's Cancer-Killing Virus in Press,Conference 2
Significantly more compact and tidier in overall looks yet retain many of the excellent features of the more comprehensive Haag type systems., ,Filters include Cobalt blue; green (red free); neut
An easy to use uncomplicated ophthalmoscope.
Comes complete in its own carrying case. There are 24 lenses, 13mm diameter -6D to +6D in 0.5D steps. Mounted in tough, yet light alloy frame.
Halberg Trial Clips have become a required addition to every refractive stand., ,These useful and inexpensive clips may be fitted over your patient's spectacle frame. Each cell has space for thre
Medicine Products: